BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33720400)

  • 21. A heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterning.
    Zhao F; Bosserhoff AK; Buettner R; Moser M
    PLoS One; 2011; 6(7):e22908. PubMed ID: 21829553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AP-2β is required for formation of the murine trabecular meshwork and Schlemm's canal.
    Akula M; Taiyab A; Deschamps P; Yee S; Ball AK; Williams T; West-Mays JA
    Exp Eye Res; 2020 Jun; 195():108042. PubMed ID: 32353428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AP-2β Is a Downstream Effector of PITX2 Required to Specify Endothelium and Establish Angiogenic Privilege During Corneal Development.
    Chen L; Martino V; Dombkowski A; Williams T; West-Mays J; Gage PJ
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1072-81. PubMed ID: 26968737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus.
    Vaughan CJ; Basson CT
    Am J Med Genet; 2000; 97(4):304-9. PubMed ID: 11376442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep Architecture in Mice Is Shaped by the Transcription Factor AP-2β.
    Nakai A; Fujiyama T; Nagata N; Kashiwagi M; Ikkyu A; Takagi M; Tatsuzawa C; Tanaka K; Kakizaki M; Kanuka M; Kawano T; Mizuno S; Sugiyama F; Takahashi S; Funato H; Sakurai T; Yanagisawa M; Hayashi Y
    Genetics; 2020 Nov; 216(3):753-764. PubMed ID: 32878901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
    Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
    J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activator Protein-2β Promotes Tumor Growth and Predicts Poor Prognosis in Breast Cancer.
    Li Z; Xu X; Luo M; Hao J; Zhao S; Yu W; Xiao X; Wu J; Zheng F; Chen M; Li Y; Qin G; Liao Y; Zhao X; Yu X; Guo W; Zou L; Deng W
    Cell Physiol Biochem; 2018; 47(5):1925-1935. PubMed ID: 29972820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factor AP-2beta: a negative regulator of IRS-1 gene expression.
    Meng X; Kondo M; Morino K; Fuke T; Obata T; Yoshizaki T; Ugi S; Nishio Y; Maeda S; Araki E; Kashiwagi A; Maegawa H
    Biochem Biophys Res Commun; 2010 Feb; 392(4):526-32. PubMed ID: 20097161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dual role of transcription factor AP-2 in carcinogenesis].
    Liang S; Deng H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):430-5. PubMed ID: 20731046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcription factors AP-2β and AP-2α are required for survival of sympathetic progenitors and differentiated sympathetic neurons.
    Schmidt M; Huber L; Majdazari A; Schütz G; Williams T; Rohrer H
    Dev Biol; 2011 Jul; 355(1):89-100. PubMed ID: 21539825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AP-2α/AP-2β Transcription Factors Are Key Regulators of Epidermal Homeostasis.
    Zhang H; Raymundo JR; Daly KE; Zhu W; Senapati B; Zhong H; Ahilan AR; Marneros AG
    J Invest Dermatol; 2024 Jul; 144(7):1505-1521.e12. PubMed ID: 38237728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional Deletion of AP-2β in the Periocular Mesenchyme of Mice Alters Corneal Epithelial Cell Fate and Stratification.
    Walker H; Taiyab A; Deschamps P; Williams T; West-Mays JA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into the pathogenesis and genetic background of patency of the ductus arteriosus.
    Bökenkamp R; DeRuiter MC; van Munsteren C; Gittenberger-de Groot AC
    Neonatology; 2010 Jun; 98(1):6-17. PubMed ID: 19955832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the noradrenaline neurotransmitter phenotype by the transcription factor AP-2beta.
    Hong SJ; Lardaro T; Oh MS; Huh Y; Ding Y; Kang UJ; Kirfel J; Buettner R; Kim KS
    J Biol Chem; 2008 Jun; 283(24):16860-7. PubMed ID: 18424435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological and behavioral correlates of polymorphisms in the transcription factor AP-2beta coding gene.
    Hensch T; Wargelius HL; Herold U; Strobel A; Oreland L; Brocke B
    Neurosci Lett; 2008 May; 436(1):67-71. PubMed ID: 18358611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological correlates of transcription factor AP-2Beta, and its interaction with COMT and MAOA in healthy females.
    Schabram I; Eggermann T; Siegel SJ; Gründer G; Zerres K; Vernaleken I
    Neuropsychobiology; 2013; 68(2):79-90. PubMed ID: 23881096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
    Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
    Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor AP-2β suppresses cervical cancer cell proliferation by promoting the degradation of its interaction partner β-catenin.
    Wang F; Huang W; Hu X; Chen C; Li X; Qiu J; Liang Z; Zhang J; Li L; Wang X; Ding X; Xiang S; Zhang J
    Mol Carcinog; 2017 Aug; 56(8):1909-1923. PubMed ID: 28277615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor AP-2beta inhibits expression and secretion of leptin, an insulin-sensitizing hormone, in 3T3-L1 adipocytes.
    Fuke T; Yoshizaki T; Kondo M; Morino K; Obata T; Ugi S; Nishio Y; Maeda S; Kashiwagi A; Maegawa H
    Int J Obes (Lond); 2010 Apr; 34(4):670-8. PubMed ID: 20065963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial patent ductus arteriosus: a further case of CHAR syndrome.
    Slavotinek A; Clayton-Smith J; Super M
    Am J Med Genet; 1997 Aug; 71(2):229-32. PubMed ID: 9217229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.